International impact of external reference pricing: should national policy makers care?

European Journal of Health Economics

3 November 2019 - External reference pricing is widely used to regulate drug prices. 

Although the literature has largely focused on the impact of ERP on a number of policy endpoints and its impact from a geographical perspective, a comparative study drawing on evidence from different settings does not exist to date.

A systematic literature review was conducted on pre-defined endpoints on the impact of external reference pricing (ERP) across countries, such as price stability, price convergence and launch delays. Expert consultation was undertaken to analyse whether or not the international implications of ERP are considered during its design.

Read European Journal of Health Economics article

Michael Wonder

Posted by:

Michael Wonder